{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:59:37Z","timestamp":1780084777491,"version":"3.54.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,28]]},"DOI":"10.7759\/cureus.84963","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:21:42Z","timestamp":1748438502000},"source":"Crossref","is-referenced-by-count":1,"title":["Chemotherapy Response as a Predictor of Survival in Post-neoadjuvant Esophagectomy Specimens"],"prefix":"10.7759","author":[{"given":"Hira","family":"Yaqub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safana","family":"Sadaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S329687","article-title":"A survival prediction nomogram for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery","volume":"13","author":"Ding T","year":"2021","unstructured":"Ding T, Liu C, Huang B, et al.. A survival prediction nomogram for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery. Cancer Manag Res. 2021, 13:7771-82. 10.2147\/CMAR.S329687","journal-title":"Cancer Manag Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14462","article-title":"Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy","volume":"1482","author":"Zhang X","year":"2020","unstructured":"Zhang X, Jain D. Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy. Ann N Y Acad Sci. 2020, 1482:163-76. 10.1111\/nyas.14462","journal-title":"Ann N Y Acad Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0995-2","article-title":"Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor","volume":"17","author":"Tong DK","year":"2010","unstructured":"Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol. 2010, 17:2184-92. 10.1245\/s10434-010-0995-2","journal-title":"Ann Surg Oncol"},{"key":"ref4","article-title":"Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer","volume":"32","author":"Morita M","year":"2012","unstructured":"Morita M, Toh Y, Saeki H, et al.. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer. Anticancer Res. 2012, 32:3275-82.","journal-title":"Anticancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.05.056","article-title":"Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients","volume":"60","author":"Liao Z","year":"2004","unstructured":"Liao Z, Zhang Z, Jin J, et al.. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys. 2004, 60:1484-93. 10.1016\/j.ijrobp.2004.05.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2006.00576.x","article-title":"Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer","volume":"19","author":"MacGuill M","year":"2006","unstructured":"MacGuill M, Mulligan E, Ravi N, et al.. Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer. Dis Esophagus. 2006, 19:273-6. 10.1111\/j.1442-2050.2006.00576.x","journal-title":"Dis Esophagus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21850","article-title":"The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas","volume":"106","author":"Br\u00fccher BL","year":"2006","unstructured":"Br\u00fccher BL, Becker K, Lordick F, et al.. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer. 2006, 106:2119-27. 10.1002\/cncr.21850","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1066896919855760","article-title":"Residual cancer volume predicts clinical outcome in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy","volume":"27","author":"Nakao R","year":"2019","unstructured":"Nakao R, Konishi E, Fujiwara H, Otsuji E, Yokota I, Urata Y, Yanagisawa A. Residual cancer volume predicts clinical outcome in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy. Int J Surg Pathol. 2019, 27:713-21. 10.1177\/1066896919855760","journal-title":"Int J Surg Pathol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.5732\/cjc.011.10390","article-title":"Epidemiologic differences in esophageal cancer between Asian and Western populations","volume":"31","author":"Zhang HZ","year":"2012","unstructured":"Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012, 31:281-6.","journal-title":"Chin J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7542-x","article-title":"Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma","volume":"29","author":"Mariette C","year":"2005","unstructured":"Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg. 2005, 29:39-45. 10.1007\/s00268-004-7542-x","journal-title":"World J Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-021-01041-5","article-title":"Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy (Article in German)","volume":"43","author":"Liu D","year":"2022","unstructured":"Liu D, Langer R. Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy (Article in German). Pathologe. 2022, 43:51-6. 10.1007\/s00292-021-01041-5","journal-title":"Pathologe"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21346","article-title":"Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus","volume":"104","author":"Rohatgi PR","year":"2005","unstructured":"Rohatgi PR, Swisher SG, Correa AM, et al.. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer. 2005, 104:1349-55. 10.1002\/cncr.21346","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20916","article-title":"Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac LR","year":"2005","unstructured":"Chirieac LR, Swisher SG, Ajani JA, et al.. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005, 103:1347-55. 10.1002\/cncr.20916","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13025","article-title":"Prognostic factors for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery","volume":"36","author":"Kitasaki N","year":"2022","unstructured":"Kitasaki N, Hamai Y, Emi M, et al.. Prognostic factors for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. In Vivo. 2022, 36:2852-60. 10.21873\/invivo.13025","journal-title":"In Vivo"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2008.11.001","article-title":"Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival","volume":"87","author":"Donahue JM","year":"2009","unstructured":"Donahue JM, Nichols FC, Li Z, et al.. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009, 87:392-8; discussion 398-9. 10.1016\/j.athoracsur.2008.11.001","journal-title":"Ann Thorac Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/his.13491","article-title":"Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial","volume":"72","author":"Davarzani N","year":"2018","unstructured":"Davarzani N, Hutchins GG, West NP, et al.. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. Histopathology. 2018, 72:1180-8. 10.1111\/his.13491","journal-title":"Histopathology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47835","article-title":"The use of trimodality treatment in patients with locally advanced oesophageal squamous cell carcinoma: an experience from a large cancer centre in Pakistan","volume":"15","author":"Qamar MF","year":"2023","unstructured":"Qamar MF, Hanif H, Haider I, Khaleeq N, Misbah D, Inam Y, Anjum M. The use of trimodality treatment in patients with locally advanced oesophageal squamous cell carcinoma: an experience from a large cancer centre in Pakistan. Cureus. 2023, 15:e47835. 10.7759\/cureus.47835","journal-title":"Cureus"},{"key":"ref18","article-title":"Efficacy and toxicity of carboplatin\/paclitaxel based chemoradiation for localized oesophageal cancer","volume":"29","author":"Qubtia M","year":"2017","unstructured":"Qubtia M, Ishaq Y, Munawar K, Badar F, Kazmi A. Efficacy and toxicity of carboplatin\/paclitaxel based chemoradiation for localized oesophageal cancer. J Ayub Med Coll Abbottabad. 2017, 29:8-12.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.07.037","article-title":"Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy","volume":"99","author":"Nieman DR","year":"2015","unstructured":"Nieman DR, Peyre CG, Watson TJ, et al.. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy. Ann Thorac Surg. 2015, 99:277-83. 10.1016\/j.athoracsur.2014.07.037","journal-title":"Ann Thorac Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doab021","article-title":"Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis","volume":"35","author":"Hagens E","year":"2022","unstructured":"Hagens E, Tukanova K, Jamel S, van Berge Henegouwen M, Hanna GB, Gisbertz S, Markar SR. Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2022, 35:doab021. 10.1093\/dote\/doab021","journal-title":"Dis Esophagus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0383-y","article-title":"Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy","volume":"18","author":"Okumura H","year":"2013","unstructured":"Okumura H, Uchikado Y, Matsumoto M, et al.. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy. Int J Clin Oncol. 2013, 18:329-34. 10.1007\/s10147-012-0383-y","journal-title":"Int J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003445","article-title":"Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in metastatic esophageal cancer","volume":"273","author":"Urakawa S","year":"2021","unstructured":"Urakawa S, Makino T, Yamasaki M, et al.. Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in metastatic esophageal cancer. Ann Surg. 2021, 273:1141-9. 10.1097\/SLA.0000000000003445","journal-title":"Ann Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182a66588","article-title":"Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard","volume":"258","author":"Donohoe CL","year":"2013","unstructured":"Donohoe CL, O'Farrell NJ, Grant T, King S, Clarke L, Muldoon C, Reynolds JV. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard. Ann Surg. 2013, 258:784-92; discussion 792. 10.1097\/SLA.0b013e3182a66588","journal-title":"Ann Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5440-8","article-title":"ypN0: does it matter how you get there? Nodal downstaging in esophageal cancer","volume":"23","author":"Zanoni A","year":"2016","unstructured":"Zanoni A, Verlato G, Giacopuzzi S, et al.. ypN0: does it matter how you get there? Nodal downstaging in esophageal cancer. Ann Surg Oncol. 2016, 23:998-1004. 10.1245\/s10434-016-5440-8","journal-title":"Ann Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.07.003","article-title":"Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes","volume":"116","author":"Tsekrekos A","year":"2021","unstructured":"Tsekrekos A, Vieth M, Ndegwa N, et al.. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes. Hum Pathol. 2021, 116:94-101. 10.1016\/j.humpath.2021.07.003","journal-title":"Hum Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.5.667","article-title":"Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer","volume":"48","author":"Dexter SP","year":"2001","unstructured":"Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001, 48:667-70. 10.1136\/gut.48.5.667","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12188","article-title":"Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma","volume":"104","author":"Shigeoka M","year":"2013","unstructured":"Shigeoka M, Urakawa N, Nakamura T, et al.. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci. 2013, 104:1112-19. 10.1111\/cas.12188","journal-title":"Cancer Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14352-z","article-title":"Potential predictive immune and metabolic biomarkers of tumor microenvironment regarding pathological and clinical response in esophageal cancer after neoadjuvant chemoradiotherapy: a systematic review","volume":"31","author":"Wang HH","year":"2024","unstructured":"Wang HH, Steffens EN, Kats-Ugurlu G, van Etten B, Burgerhof JG, Hospers GA, Plukker JT. Potential predictive immune and metabolic biomarkers of tumor microenvironment regarding pathological and clinical response in esophageal cancer after neoadjuvant chemoradiotherapy: a systematic review. Ann Surg Oncol. 2024, 31:433-51. 10.1245\/s10434-023-14352-z","journal-title":"Ann Surg Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1356147","article-title":"Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma","volume":"6","author":"Li Y","year":"2017","unstructured":"Li Y, Lu Z, Che Y, et al.. Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma. Oncoimmunology. 2017, 6:e1356147. 10.1080\/2162402X.2017.1356147","journal-title":"Oncoimmunology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359963-chemotherapy-response-as-a-predictor-of-survival-in-post-neoadjuvant-esophagectomy-specimens","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:21:43Z","timestamp":1748438503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359963-chemotherapy-response-as-a-predictor-of-survival-in-post-neoadjuvant-esophagectomy-specimens"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.84963","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}